For the Inventor, By the Inventor

Enter assignee name

Orient Bio., Inc.

USPTO Granted Patents = 1

% Expired Patents = 100.0

Forward Citations = 30

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

Daesoo Kim (1 out of 10 patents)

Hee-Sup Shin (1 out of 3 patents)

Sehoon Keum (1 out of 1 patent)

4. Inseon Song (1 out of 1 patent)

1 patent: Sort by Forward Citations

1. 7626076 - Transgenic mouse whose genome comprises a homozygous disruption of its α1G gene, a method of preparing the same and use thereof (2009-12-01),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

1 Patents

#384 in

#5,784 in South Korea

Orient Bio., Inc.

Forward Citations = 30

4 inventors:

Daesoo Kim (1 out of 10 patents)

Hee-Sup Shin (1 out of 3 patents)

Sehoon Keum (1 out of 1 patent)

4. Inseon Song (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orient Bio., Inc.. Retrieved from https://idiyas.com/company/orient-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…